Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels P Kocsis, S Farkas, L Fodor, N Bielik, M Thán, S Kolok, A Gere, M Csejtei, ... Journal of Pharmacology and Experimental Therapeutics 315 (3), 1237-1246, 2005 | 100 | 2005 |
Tumor volume estimation and quasi-continuous administration for most effective bevacizumab therapy J Sápi, L Kovács, DA Drexler, P Kocsis, D Gajári, Z Sápi PloS one 10 (11), e0142190, 2015 | 96 | 2015 |
Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases I Tarnawa, H Bolcskei, P Kocsis Recent Patents on CNS Drug Discovery (Discontinued) 2 (1), 57-78, 2007 | 93 | 2007 |
Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs S Farkas, P Berzsenyi, E Kárpáti, P Kocsis, I Tarnawa Journal of Pharmacological and Toxicological methods 52 (2), 264-273, 2005 | 56 | 2005 |
Estradiol and isotype-selective estrogen receptor agonists modulate the mesocortical dopaminergic system in gonadectomized female rats M Sárvári, L Deli, P Kocsis, L Márk, G Maász, E Hrabovszky, I Kalló, ... Brain research 1583, 1-11, 2014 | 44 | 2014 |
NR2B containing NMDA receptor dependent windup of single spinal neurons G Kovács, P Kocsis, I Tarnawa, C Horváth, Z Szombathelyi, S Farkas Neuropharmacology 46 (1), 23-30, 2004 | 37 | 2004 |
Central sensitization-related changes of effective and functional connectivity in the rat inflammatory trigeminal pain model T Spisák, Z Pozsgay, C Aranyi, S Dávid, P Kocsis, G Nyitrai, D Gajári, ... Neuroscience 344, 133-147, 2017 | 27 | 2017 |
Comparative characterisation of the centrally acting muscle relaxant RGH-5002 and tolperisone and of lidocaine based on their effects on rat spinal cord in vitro. S Farkas, P Kocsis, N Bielik Neurobiology (Budapest, Hungary) 5 (1), 57-58, 1997 | 27 | 1997 |
Ghrelin modulates the fMRI BOLD response of homeostatic and hedonic brain centers regulating energy balance in the rat M Sarvari, P Kocsis, L Deli, D Gajari, S David, Z Pozsgay, N Hegedűs, ... PLoS One 9 (5), e97651, 2014 | 17 | 2014 |
Vascular action as the primary mechanism of cognitive effects of cholinergic, CNS-acting drugs, a rat phMRI BOLD study P Kocsis, I Gyertyán, J Éles, J Laszy, N Hegedüs, D Gajári, L Deli, ... Journal of Cerebral Blood Flow & Metabolism 34 (6), 995-1000, 2014 | 16 | 2014 |
Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD P Kocsis, I Tarnawa, G Kovács, Z Szombathelyi, S Farkas Acta Pharmaceutica Hungarica 72 (1), 49-61, 2002 | 16 | 2002 |
Effect of tolperisone on the resting brain and on evoked responses, an phMRI BOLD study P Kocsis, D Gajári, L Deli, KZ Gőcze, Z Pozsgay, K Tihanyi Brain Research Bulletin 99, 34-40, 2013 | 15 | 2013 |
Concerted action of antiepileptic and antidepressant agents to depress spinal neurotransmission: Possible use in the therapy of spasticity and chronic pain M Thán, P Kocsis, K Tihanyi, L Fodor, B Farkas, G Kovács, Á Kis-Varga, ... Neurochemistry international 50 (4), 642-652, 2007 | 15 | 2007 |
Voltage-gated sodium channel blockers, 2001-2006: An overview H Bölcskei, I Tarnawa, P Kocsis Medicinal Chemistry Research 17, 356-368, 2008 | 13 | 2008 |
Recent advancements in anti-migraine drug research: focus on attempts to decrease neuronal hyperexcitability H Bolcskei, B Farkas, P Kocsis, I Tarnawa Recent Patents on CNS Drug Discovery (Discontinued) 4 (1), 14-36, 2009 | 11 | 2009 |
Participation of AMPA-and NMDA-type excitatory amino acid receptors in the spinal reflex transmission, in rat P Kocsis, I Tarnawa, Z Szombathelyi, S Farkas Brain research bulletin 60 (1-2), 81-91, 2003 | 10 | 2003 |
Scopolamine provocation-based pharmacological MRI model for testing procognitive agents N Hegedűs, J Laszy, I Gyertyán, P Kocsis, D Gajári, S Dávid, L Deli, ... Journal of Psychopharmacology 29 (4), 447-455, 2015 | 9 | 2015 |
Effect of glutamate receptor antagonists on excitatory postsynaptic potentials in striatum I Világi, P Kocsis, I Tarnawa, I Banczerowski-Pelyhe Brain research bulletin 46 (6), 483-486, 1998 | 8 | 1998 |
Analysis of the mechanism of action, relationship between pharmacodynamics and pharmacokinetics of silperisone, a new centrally acting muscle relaxant S Farkas, P Kocsis, N Bielik, L Gémesi, G Trafikânt Fundam. Clin. Pharmacol 13 (1), 1999 | 7 | 1999 |
NR2B receptors are involved in the mediation of spinal segmental reflex potentials but not in the cumulative motoneuronal depolarization in vitro P Kocsis, G Kovács, S Farkas, C Horváth, Z Szombathelyi, I Tarnawa Brain research bulletin 64 (2), 133-138, 2004 | 5 | 2004 |